TXMD - TherapeuticsMD, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts7777
Avg. Estimate-0.17-0.18-0.69-0.2
Low Estimate-0.18-0.21-0.75-0.64
High Estimate-0.16-0.15-0.640.22
Year Ago EPS-0.15-0.16-0.59-0.69
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts6677
Avg. Estimate6.46M10.63M37.83M181.96M
Low Estimate4.74M8.05M26.39M44.87M
High Estimate8.2M12.02M44.58M300.81M
Year Ago Sales3.76MN/A16.1M37.83M
Sales Growth (year/est)71.70%N/A135.00%381.00%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.12-0.21-0.17-0.17
EPS Actual-0.15-0.16-0.17-0.16
Difference-0.030.0500.01
Surprise %-25.00%23.80%0.00%5.90%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.17-0.18-0.69-0.2
7 Days Ago-0.17-0.18-0.69-0.2
30 Days Ago-0.16-0.16-0.65-0.08
60 Days Ago-0.17-0.16-0.65-0.06
90 Days Ago-0.17-0.16-0.62-0.02
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days111N/A
Up Last 30 Days111N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days2442
Growth EstimatesTXMDIndustrySectorS&P 500
Current Qtr.-13.30%N/AN/A0.02
Next Qtr.-12.50%N/AN/A0.04
Current Year-16.90%N/AN/A0.05
Next Year71.00%N/AN/A0.11
Next 5 Years (per annum)19.50%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A